Department of Tumor Pathology, Hamamatsu University School of Medicine, Shizuoka 431-3192, Japan.
World J Gastroenterol. 2012 Dec 21;18(47):6935-42. doi: 10.3748/wjg.v18.i47.6935.
To investigate the suppressive activity of MUTYH variant proteins against mutations caused by oxidative lesion, 8-hydroxyguanine (8OHG), in human cells.
p.R154H, p.M255V, p.L360P, and p.P377L MUTYH variants, which were previously found in patients with colorectal polyposis and cancer, were selected for use in this study. Human H1299 cancer cell lines inducibly expressing wild-type (WT) MUTYH (type 2) or one of the 4 above-mentioned MUTYH variants were established using the piggyBac transposon vector system, enabling the genomic integration of the transposon sequence for MUTYH expression. MUTYH expression was examined after cumate induction using Western blotting analysis and immunofluorescence analysis. The intracellular localization of MUTYH variants tagged with FLAG was also immunofluorescently examined. Next, the mutation frequency in the supF of the shuttle plasmid pMY189 containing a single 8OHG residue at position 159 of the supF was compared between empty vector cells and cells expressing WT MUTYH or one of the 4 MUTYH variants using a supF forward mutation assay.
The successful establishment of human cell lines inducibly expressing WT MUTYH or one of the 4 MUTYH variants was concluded based on the detection of MUTYH expression in these cell lines after treatment with cumate. All of the MUTYH variants and WT MUTYH were localized in the nucleus, and nuclear localization was also observed for FLAG-tagged MUTYH. The mutation frequency of supF was 2.2 × 10(-2) in the 8OHG-containing pMY189 plasmid and 2.5 × 10(-4) in WT pMY189 in empty vector cells, which was an 86-fold increase with the introduction of 8OHG. The mutation frequency (4.7 × 10(-3)) of supF in the 8OHG-containing pMY189 plasmid in cells overexpressing WT MUTYH was significantly lower than in the empty vector cells (P < 0.01). However, the mutation frequencies of the supF in the 8OHG-containing pMY189 plasmid in cells overexpressing the p.R154H, p.M255V, p.L360P, or p.P377L MUTYH variant were 1.84 × 10(-2), 1.55 × 10(-2), 1.91 × 10(-2), and 1.96 × 10(-2), respectively, meaning that no significant difference was observed in the mutation frequency between the empty vector cells and cells overexpressing MUTYH mutants.
The suppressive activities of p.R154H, p.M255V, p.L360P, and p.P377L MUTYH variants against mutations caused by 8OHG are thought to be severely impaired in human cells.
研究 MUTYH 变异蛋白对人细胞中氧化损伤引起的 8-羟基鸟嘌呤(8OHG)突变的抑制活性。
选择先前在结直肠息肉病和癌症患者中发现的 p.R154H、p.M255V、p.L360P 和 p.P377L MUTYH 变异体用于本研究。使用 piggyBac 转座子载体系统建立了可诱导表达野生型(WT)MUTYH(2 型)或上述 4 种 MUTYH 变异体之一的人 H1299 癌细胞系,使转座子序列的基因组整合用于 MUTYH 表达。使用 cumate 诱导后,通过 Western blot 分析和免疫荧光分析检查 MUTYH 的表达。还通过免疫荧光检查了标记有 FLAG 的 MUTYH 变体的细胞内定位。接下来,使用 supF 正向突变测定法比较了含有位置 159 处单个 8OHG 残基的穿梭质粒 pMY189 中 supF 中的突变频率,该质粒位于空载体细胞和表达 WT MUTYH 或 4 种 MUTYH 变异体之一的细胞之间。
根据 cumate 处理后这些细胞系中 MUTYH 表达的检测,得出成功建立了可诱导表达 WT MUTYH 或 4 种 MUTYH 变异体之一的人细胞系的结论。所有 MUTYH 变体和 WT MUTYH 均定位于核内,并且在 FLAG 标记的 MUTYH 中也观察到核定位。含有 8OHG 的 pMY189 质粒中 supF 的突变频率为 2.2×10(-2),空载体细胞中 WT pMY189 中的突变频率为 2.5×10(-4),引入 8OHG 后增加了 86 倍。在过表达 WT MUTYH 的细胞中,含有 8OHG 的 pMY189 质粒中 supF 的突变频率(4.7×10(-3))明显低于空载体细胞(P<0.01)。然而,在过表达 p.R154H、p.M255V、p.L360P 或 p.P377L MUTYH 变异体的含有 8OHG 的 pMY189 质粒中 supF 的突变频率分别为 1.84×10(-2)、1.55×10(-2)、1.91×10(-2)和 1.96×10(-2),这意味着在空载体细胞和过表达 MUTYH 突变体的细胞之间未观察到突变频率的显著差异。
p.R154H、p.M255V、p.L360P 和 p.P377L MUTYH 变体对 8OHG 引起的突变的抑制活性被认为在人细胞中严重受损。